Health catalyst, inc. HCAT.US Overview
HCAT AI Analysis & Strategy
Analysis Conclusion
The stock, with its moderate value rating, suggests that existing positions can be retained. For initiating new positions, it's advisable to wait for a value score above 4 and a dividend score of 2 or higher.
HCAT Current Performance
-
Health catalyst, inc.
0.98%
Avg of Sector
0.83%
S&P500
HCAT Key Information
HCAT Financial Forecast
Unit : USD
HCAT Earnings Table
Unit : USD
| QTR | Non-GAAP EPS | EPS YoY | EPS Surprise % | Sales | Sales YoY | Sales Surprise % | NPM |
|---|---|---|---|---|---|---|---|
| Current | 0.01 | -80% | 0% | 79.41M | 6.3% | 0.3% | -26% |
| 2024Q3 | 0.04 | 100% | -63.6% | 79.61M | 6% | 0% | -19.3% |
| 2024Q2 | 0.07 | 133.3% | -30% | 76.35M | 3.5% | -5.4% | -17.8% |
| 2024Q1 | 0.12 | 140% | 33.3% | 75.9M | 3.7% | 1.2% | -27.6% |
| 2023Q4 | 0.05 | 0% | 79% | 74.72M | 1.2% | -0.1% | -40.4% |
HCAT Profile
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
Price of HCAT
HCAT FAQ
When is HCAT's latest earnings report released?
The most recent financial report for Health catalyst, inc. (HCAT) covers the period of 2025Q1 and was published on 2025/03/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating HCAT’s short-term business performance and financial health. For the latest updates on HCAT’s earnings releases, visit this page regularly.
What is the operating profit of HCAT?
According to the latest financial report, Health catalyst, inc. (HCAT) reported an Operating Profit of -20.17M with an Operating Margin of -25.4% this period, representing a growth of 11.58% compared to the same period last year. Operating Profit reflects the company’s core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.
How is HCAT's revenue growth?
In the latest financial report, Health catalyst, inc. (HCAT) announced revenue of 79.41M, with a Year-Over-Year growth rate of 6.28%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.
How much debt does HCAT have?
As of the end of the reporting period, Health catalyst, inc. (HCAT) had total debt of 402.37M, with a debt ratio of 0.28. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company’s capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.
How much cash does HCAT have?
At the end of the period, Health catalyst, inc. (HCAT) held Total Cash and Cash Equivalents of 341.97M, accounting for 0.38 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.
Does HCAT go with three margins increasing?
In the latest report, Health catalyst, inc. (HCAT) did not achieve the “three margins increasing” benchmark, with a gross margin of 45.6%%, operating margin of -25.4%%, and net margin of -29.9%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess HCAT’s profit trajectory and future growth potential.
What is the FCF of HCAT?
Health catalyst, inc. (HCAT)’s Free Cash Flow (FCF) for the period is -5.04M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 166.98% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.
What are the PEG ratio and PE ratio of HCAT?
The latest valuation data shows Health catalyst, inc. (HCAT) has a Price-To-Earnings (PE) ratio of -3.96 and a Price/Earnings-To-Growth (PEG) ratio of -0.54. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.